Uyanga Batzorig

6PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Homer3 Promotes Aggressive Phenotypes in Triple-Negative Breast Cancer Through Cell Cycle- and MYC-Associated Programs.

|Mar 27, 2026
The transcription elongation factors Spt4 and Spt6 promote dermal adipocyte differentiation.

Julian Gomez, Samiksha Mahapatra, Uyanga Batzorig

|Oct 28, 2023
CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.

Cheng-Chin Lee, Kuei-Yen Tsai, Ai-Wei Lee

|Jul 14, 2023
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.

Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig

|May 27, 2023
The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity.

Chien-Yu Huang, Po-Li Wei, G M Shazzad Hossain Prince

|Feb 18, 2022
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.

Wei-Lin Wang, Uyanga Batzorig, Chin-Sheng Hung

Pageof 1

Frequent Collaborators

5 joint publications

Yu-Jia Chang

4 joint publications

Po-Li Wei

3 joint publications

Chin-Sheng Hung

2 joint publications

G M Shazzad Hossain Prince